{"pmid":32423262,"title":"Psychological status of postpartum women under the COVID-19 pandemic in Japan.","text":["Psychological status of postpartum women under the COVID-19 pandemic in Japan.","Under the COVID-19 (Coronavirus Disease 2019) pandemic, limitations are known to cause some psychosocial problems. We compared the results of mental screening of the postpartum women conducted during the COVID-19 epidemic with those at the same period last year. Based on the results, the worse mother-infant bonding was suspected at 1 month after birth under the COVID-19 pandemic.","J Matern Fetal Neonatal Med","Suzuki, Shunji","32423262"],"abstract":["Under the COVID-19 (Coronavirus Disease 2019) pandemic, limitations are known to cause some psychosocial problems. We compared the results of mental screening of the postpartum women conducted during the COVID-19 epidemic with those at the same period last year. Based on the results, the worse mother-infant bonding was suspected at 1 month after birth under the COVID-19 pandemic."],"journal":"J Matern Fetal Neonatal Med","authors":["Suzuki, Shunji"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32423262","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/14767058.2020.1763949","keywords":["covid-19 pandemic","japan","mother-infant bonding","one month after birth"],"locations":["Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"weight":0,"_version_":1667352728693637120,"score":9.490897,"similar":[{"pmid":32474910,"title":"Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period.","text":["Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period.","OBJECTIVE: To explore whether quarantine measures and hospital containment policies among women giving birth in a COVID-19 \"hotspot\" area in northeastern Italy enhanced psycho-emotional distress in the immediate postpartum period. METHODS: We designed a non-concurrent case-control study of mothers who gave birth during a COVID-19 quarantine period between March 8 and May 3, 2020 (COVID-19 study group), with an antecedent group of matched postpartum women (control group) who delivered in the same period in 2019. Participants completed the Edinburgh Postnatal Depression Scale (EPDS) on the second day postpartum. RESULTS: The COVID-19 study group (n=91) had significantly higher mean EPDS scores compared with the control group (n=101) (8.5 +/- 4.6 vs 6.34 +/- 4.1; P<0.001). Furthermore, 26% of women in the COVID-19 group had a global EPDS score above 12. Analysis of three EPDS subscales revealed significantly higher scores among the COVID-19 group compared with the control group for anhedonia (0.60 +/- 0.61 vs 0.19 +/- 0.36; P<0.001) and depression (0.58 +/- 0.54 vs 0.35 +/- 0.45; P=0.001). CONCLUSIONS: Concerns about risk of exposure to COVID-19, combined with quarantine measures adopted during the COVID-19 pandemic, adversely affected the thoughts and emotions of new mothers, worsening depressive symptoms.","Int J Gynaecol Obstet","Zanardo, Vincenzo","Manghina, Valeria","Giliberti, Lara","Vettore, Michela","Severino, Lorenzo","Straface, Gianluca","32474910"],"abstract":["OBJECTIVE: To explore whether quarantine measures and hospital containment policies among women giving birth in a COVID-19 \"hotspot\" area in northeastern Italy enhanced psycho-emotional distress in the immediate postpartum period. METHODS: We designed a non-concurrent case-control study of mothers who gave birth during a COVID-19 quarantine period between March 8 and May 3, 2020 (COVID-19 study group), with an antecedent group of matched postpartum women (control group) who delivered in the same period in 2019. Participants completed the Edinburgh Postnatal Depression Scale (EPDS) on the second day postpartum. RESULTS: The COVID-19 study group (n=91) had significantly higher mean EPDS scores compared with the control group (n=101) (8.5 +/- 4.6 vs 6.34 +/- 4.1; P<0.001). Furthermore, 26% of women in the COVID-19 group had a global EPDS score above 12. Analysis of three EPDS subscales revealed significantly higher scores among the COVID-19 group compared with the control group for anhedonia (0.60 +/- 0.61 vs 0.19 +/- 0.36; P<0.001) and depression (0.58 +/- 0.54 vs 0.35 +/- 0.45; P=0.001). CONCLUSIONS: Concerns about risk of exposure to COVID-19, combined with quarantine measures adopted during the COVID-19 pandemic, adversely affected the thoughts and emotions of new mothers, worsening depressive symptoms."],"journal":"Int J Gynaecol Obstet","authors":["Zanardo, Vincenzo","Manghina, Valeria","Giliberti, Lara","Vettore, Michela","Severino, Lorenzo","Straface, Gianluca"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474910","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/ijgo.13249","keywords":["anhedonia","anxiety","covid-19","coronavirus","depression","edinburgh postnatal depression scale","postpartum period","quarantine"],"locations":["Italy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1668341932719341569,"score":124.257286},{"pmid":32294503,"pmcid":"PMC7152867","title":"Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019.","text":["Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019.","BACKGROUND: 2019 novel coronavirus disease (COVID-19) has become a worldwide pandemic. Under such circumstance pregnant women are also affected significantly. OBJECTIVE: This study aims to observe the clinical features and outcomes of pregnant women who have been confirmed with COVID-19. METHODS: The research objects were 55 cases of suspected COVID-19 pregnant women who gave a birth from Jan 20th 2020 to Mar 5th 2020 in our hospital-a big birth center delivering about 30,000 babies in the last 3 years. These cases were subjected to pulmonary CT scan and routine blood test, manifested symptoms of fever, cough, chest tightness or gastrointestinal symptoms. They were admitted to an isolated suite, with clinical features and newborn babies being carefully observed. Among the 55 cases, 13 patients were assigned into the confirmed COVID-19 group for being tested positive sever acute respiratory syndrome coronavirus 2(SARS-CoV-2) via maternal throat swab test, and the other 42 patients were assigned into the control group for being ruled out COVID-19 pneumonia based on new coronavirus pneumonia prevention and control program(the 7th edition). RESULTS: There were 2 fever patients during the prenatal period and 8 fever patients during the postpartum period in the confirmed COVID-19 group. In contrast, there were 11 prenatal fever patients and 20 postpartum fever patients in the control group (p>0.05). Among 55 cases, only 2 case had cough in the confirmed group. The imaging of pulmonary CT scan showed ground- glass opacity (46.2%, 6/13), patch-like shadows(38.5%, 5/13), fiber shadow(23.1%, 3/13), pleural effusion (38.5%, 5/13)and pleural thickening(7.7%, 1/13), and there was no statistical difference between the confirmed COVID-19 group and the control group (p>0.05). During the prenatal and postpartum period, there was no difference in the count of WBC, Neutrophils and Lymphocyte, the radio of Neutrophils and Lymphocyte and the level of CRP between the confirmed COVID-19 group and the control group(p<0.05). 20 babies (from confirmed mother and from normal mother) were subjected to SARS-CoV-2 examination by throat swab samples in 24 h after birth and no case was tested positive. CONCLUSION: The clinical symptoms and laboratory indicators are not obvious for asymptomatic and mild COVID-19 pregnant women. Pulmonary CT scan plus blood routine examination are more suitable for finding pregnancy women with asymptomatic or mild COVID-19 infection, and can be used screening COVID-19 pregnant women in the outbreak area of COVID-19 infection.","J Infect","Yang, Hui","Sun, Guoqiang","Tang, Fei","Peng, Min","Gao, Ying","Peng, Jing","Xie, Hui","Zhao, Yun","Jin, Zhichun","32294503"],"abstract":["BACKGROUND: 2019 novel coronavirus disease (COVID-19) has become a worldwide pandemic. Under such circumstance pregnant women are also affected significantly. OBJECTIVE: This study aims to observe the clinical features and outcomes of pregnant women who have been confirmed with COVID-19. METHODS: The research objects were 55 cases of suspected COVID-19 pregnant women who gave a birth from Jan 20th 2020 to Mar 5th 2020 in our hospital-a big birth center delivering about 30,000 babies in the last 3 years. These cases were subjected to pulmonary CT scan and routine blood test, manifested symptoms of fever, cough, chest tightness or gastrointestinal symptoms. They were admitted to an isolated suite, with clinical features and newborn babies being carefully observed. Among the 55 cases, 13 patients were assigned into the confirmed COVID-19 group for being tested positive sever acute respiratory syndrome coronavirus 2(SARS-CoV-2) via maternal throat swab test, and the other 42 patients were assigned into the control group for being ruled out COVID-19 pneumonia based on new coronavirus pneumonia prevention and control program(the 7th edition). RESULTS: There were 2 fever patients during the prenatal period and 8 fever patients during the postpartum period in the confirmed COVID-19 group. In contrast, there were 11 prenatal fever patients and 20 postpartum fever patients in the control group (p>0.05). Among 55 cases, only 2 case had cough in the confirmed group. The imaging of pulmonary CT scan showed ground- glass opacity (46.2%, 6/13), patch-like shadows(38.5%, 5/13), fiber shadow(23.1%, 3/13), pleural effusion (38.5%, 5/13)and pleural thickening(7.7%, 1/13), and there was no statistical difference between the confirmed COVID-19 group and the control group (p>0.05). During the prenatal and postpartum period, there was no difference in the count of WBC, Neutrophils and Lymphocyte, the radio of Neutrophils and Lymphocyte and the level of CRP between the confirmed COVID-19 group and the control group(p<0.05). 20 babies (from confirmed mother and from normal mother) were subjected to SARS-CoV-2 examination by throat swab samples in 24 h after birth and no case was tested positive. CONCLUSION: The clinical symptoms and laboratory indicators are not obvious for asymptomatic and mild COVID-19 pregnant women. Pulmonary CT scan plus blood routine examination are more suitable for finding pregnancy women with asymptomatic or mild COVID-19 infection, and can be used screening COVID-19 pregnant women in the outbreak area of COVID-19 infection."],"journal":"J Infect","authors":["Yang, Hui","Sun, Guoqiang","Tang, Fei","Peng, Min","Gao, Ying","Peng, Jing","Xie, Hui","Zhao, Yun","Jin, Zhichun"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294503","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jinf.2020.04.003","keywords":["covid-19","novel cornonavirus","outcomes","pregnant women","pulmonary ct scan"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494345412609,"score":100.90637},{"pmid":32386441,"title":"Pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden.","text":["Pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden.","The Public Health Agency of Sweden has analysed how many pregnant and postpartum women with SARS-CoV-2 infection have been treated in intensive care units (ICU) in Sweden between the March 19 and April 20, 2020, compared with non-pregnant women of similar age. Cases were identified in a special reporting module within the Swedish Intensive Care Registry (SIR). Fifty-three women aged 20-45 years with SARS-CoV-2 were reported in SIR, and thirteen (n=13) of these women were either pregnant or postpartum (<1 week). The results indicate that the risk of being admitted to ICU may be higher in pregnant and postpartum women with laboratory-confirmed SARS-CoV-2 in Sweden, compared to non-pregnant women of similar age.","Acta Obstet Gynecol Scand","Collin, Julius","Bystrom, Emma","Carnahan, AnnaSara","Ahrne, Malin","32386441"],"abstract":["The Public Health Agency of Sweden has analysed how many pregnant and postpartum women with SARS-CoV-2 infection have been treated in intensive care units (ICU) in Sweden between the March 19 and April 20, 2020, compared with non-pregnant women of similar age. Cases were identified in a special reporting module within the Swedish Intensive Care Registry (SIR). Fifty-three women aged 20-45 years with SARS-CoV-2 were reported in SIR, and thirteen (n=13) of these women were either pregnant or postpartum (<1 week). The results indicate that the risk of being admitted to ICU may be higher in pregnant and postpartum women with laboratory-confirmed SARS-CoV-2 in Sweden, compared to non-pregnant women of similar age."],"journal":"Acta Obstet Gynecol Scand","authors":["Collin, Julius","Bystrom, Emma","Carnahan, AnnaSara","Ahrne, Malin"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32386441","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/aogs.13901","keywords":["covid-19","coronavirus","icu","intensive care","postpartum","pregnancy","sars-cov-2"],"locations":["Sweden","Sweden","Sweden","Sweden"],"countries":["Sweden"],"countries_codes":["SWE|Sweden"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666340102071123968,"score":95.47222},{"pmid":32474140,"title":"Maternal choline and respiratory coronavirus effects on fetal brain development.","text":["Maternal choline and respiratory coronavirus effects on fetal brain development.","Prenatal COVID-19 infection is anticipated by the U.S. Centers for Disease Control to affect fetal development similarly to other common respiratory coronaviruses through effects of the maternal inflammatory response on the fetus and placenta. Plasma choline levels were measured at 16 weeks gestation in 43 mothers who had contracted common respiratory viruses during the first 6-16 weeks of pregnancy and 53 mothers who had not. When their infants reached 3 months of age, mothers completed the Infant Behavior Questionnaire-Revised (IBQ-R), which assesses their infants' level of activity (Surgency), their fearfulness and sadness (Negativity), and their ability to maintain attention and bond to their parents and caretakers (Regulation). Infants of mothers who had contracted a moderately severe respiratory virus infection and had higher gestational choline serum levels (>/=7.5 mM consistent with U.S. Food and Drug Administration dietary recommendations) had significantly increased development of their ability to maintain attention and to bond with their parents (Regulation), compared to infants whose mothers had contracted an infection but had lower choline levels (<7.5 mM). For infants of mothers with choline levels >/=7.5 muM, there was no effect of viral infection on infant IBQ-R Regulation, compared to infants of mothers who were not infected. Higher choline levels obtained through diet or supplements may protect fetal development and support infant early behavioral development even if the mother contracts a viral infection in early gestation when the brain is first being formed.","J Psychiatr Res","Freedman, Robert","Hunter, Sharon K","Law, Amanda J","D'Alessandro, Angelo","Noonan, Kathleen","Wyrwa, Anna","Camille Hoffman, M","32474140"],"abstract":["Prenatal COVID-19 infection is anticipated by the U.S. Centers for Disease Control to affect fetal development similarly to other common respiratory coronaviruses through effects of the maternal inflammatory response on the fetus and placenta. Plasma choline levels were measured at 16 weeks gestation in 43 mothers who had contracted common respiratory viruses during the first 6-16 weeks of pregnancy and 53 mothers who had not. When their infants reached 3 months of age, mothers completed the Infant Behavior Questionnaire-Revised (IBQ-R), which assesses their infants' level of activity (Surgency), their fearfulness and sadness (Negativity), and their ability to maintain attention and bond to their parents and caretakers (Regulation). Infants of mothers who had contracted a moderately severe respiratory virus infection and had higher gestational choline serum levels (>/=7.5 mM consistent with U.S. Food and Drug Administration dietary recommendations) had significantly increased development of their ability to maintain attention and to bond with their parents (Regulation), compared to infants whose mothers had contracted an infection but had lower choline levels (<7.5 mM). For infants of mothers with choline levels >/=7.5 muM, there was no effect of viral infection on infant IBQ-R Regulation, compared to infants of mothers who were not infected. Higher choline levels obtained through diet or supplements may protect fetal development and support infant early behavioral development even if the mother contracts a viral infection in early gestation when the brain is first being formed."],"journal":"J Psychiatr Res","authors":["Freedman, Robert","Hunter, Sharon K","Law, Amanda J","D'Alessandro, Angelo","Noonan, Kathleen","Wyrwa, Anna","Camille Hoffman, M"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474140","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jpsychires.2020.05.019","keywords":["attention","child development","choline","coronavirus","phosphatidylcholine","pregnancy"],"weight":0,"_version_":1668341932760236032,"score":84.4285},{"pmid":32249918,"pmcid":"PMC7184430","title":"Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study.","text":["Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study.","BACKGROUND: The ongoing epidemics of coronavirus disease 2019 (COVID-19) have caused serious concerns about its potential adverse effects on pregnancy. There are limited data on maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia. METHODS: We conducted a case-control study to compare clinical characteristics, maternal and neonatal outcomes of pregnant women with and without COVID-19 pneumonia. RESULTS: During January 24 to February 29, 2020, there were sixteen pregnant women with confirmed COVID-19 pneumonia and eighteen suspected cases who were admitted to labor in the third trimester. Two had vaginal delivery and the rest took cesarean section. Few patients presented respiratory symptoms (fever and cough) on admission, but most had typical chest CT images of COVID-19 pneumonia. Compared to the controls, COVID-19 pneumonia patients had lower counts of white blood cells (WBC), neutrophils, C-reactive protein (CRP), and alanine aminotransferase (ALT) on admission. Increased levels of WBC, neutrophils, eosinophils, and CRP were found in postpartum blood tests of pneumonia patients. There were three (18.8%) and three (16.7%) of the mothers with confirmed or suspected COVID-19 pneumonia had preterm delivery due to maternal complications, which were significantly higher than the control group. None experienced respiratory failure during hospital stay. COVID-19 infection was not found in the newborns and none developed severe neonatal complications. CONCLUSION: Severe maternal and neonatal complications were not observed in pregnant women with COVID-19 pneumonia who had vaginal delivery or caesarean section. Mild respiratory symptoms of pregnant women with COVID-19 pneumonia highlight the need of effective screening on admission.","Clin Infect Dis","Li, Na","Han, Lefei","Peng, Min","Lv, Yuxia","Ouyang, Yin","Liu, Kui","Yue, Linli","Li, Qiannan","Sun, Guoqiang","Chen, Lin","Yang, Lin","32249918"],"abstract":["BACKGROUND: The ongoing epidemics of coronavirus disease 2019 (COVID-19) have caused serious concerns about its potential adverse effects on pregnancy. There are limited data on maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia. METHODS: We conducted a case-control study to compare clinical characteristics, maternal and neonatal outcomes of pregnant women with and without COVID-19 pneumonia. RESULTS: During January 24 to February 29, 2020, there were sixteen pregnant women with confirmed COVID-19 pneumonia and eighteen suspected cases who were admitted to labor in the third trimester. Two had vaginal delivery and the rest took cesarean section. Few patients presented respiratory symptoms (fever and cough) on admission, but most had typical chest CT images of COVID-19 pneumonia. Compared to the controls, COVID-19 pneumonia patients had lower counts of white blood cells (WBC), neutrophils, C-reactive protein (CRP), and alanine aminotransferase (ALT) on admission. Increased levels of WBC, neutrophils, eosinophils, and CRP were found in postpartum blood tests of pneumonia patients. There were three (18.8%) and three (16.7%) of the mothers with confirmed or suspected COVID-19 pneumonia had preterm delivery due to maternal complications, which were significantly higher than the control group. None experienced respiratory failure during hospital stay. COVID-19 infection was not found in the newborns and none developed severe neonatal complications. CONCLUSION: Severe maternal and neonatal complications were not observed in pregnant women with COVID-19 pneumonia who had vaginal delivery or caesarean section. Mild respiratory symptoms of pregnant women with COVID-19 pneumonia highlight the need of effective screening on admission."],"journal":"Clin Infect Dis","authors":["Li, Na","Han, Lefei","Peng, Min","Lv, Yuxia","Ouyang, Yin","Liu, Kui","Yue, Linli","Li, Qiannan","Sun, Guoqiang","Chen, Lin","Yang, Lin"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249918","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cid/ciaa352","topics":["Diagnosis"],"weight":1,"_version_":1666138490973192192,"score":81.733116}]}